The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.
Also called NCT02254655
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose supportive care
- Phase
- Phase 2
- Enrolled
- 119 participants
- Sponsor
- Chengdu PLA General Hospital
- Registry
-
NCT02254655
-
- Other papers using this trial's data
- The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: ARandomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02254655. Randomized; single masking; primary purpose supportive care. Start 2013-11 (actual); primary completion 2017-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis
- Condition
- Rheumatoid Arthritis
- Intervention (Drug)
- Puerarin injection 400 mg
- Intervention (Drug)
- Control
- Lead sponsor
- Chengdu PLA General Hospital
Record details
- Record id
cardio:ct-nct02254655- Content hash
a8682bbfb16bc60f0028d06083fd624bde7adebb1dbc5e50a97690eb47a06e63